Cardiac Rhythm Management Devices Market, By Product (Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices), By Application (Congestive heart failure, Arrhythmias, Bradycardia, Tachycardia, and Others), By End users (Hospitals, Cardiac care centers, Ambulatory surgical centers, Other), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025

Code : CMI2364

Pages :155

Formats :

Excel and PDF

Industry : Medical Devices

Cardiac Rhythm Management Devices Market Size and Trends

Global cardiac rhythm management devices market is estimated to be valued at USD 18.25 Bn in 2025 and is expected to reach USD 24.35 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4% from 2025 to 2032. The market growth is driven by rising global prevalence of cardiac arrhythmias and growing geriatric population worldwide who are more prone to developing such conditions.

Cardiac Rhythm Management Devices Market key Factors

To learn more about this report, Request sample copy

Global cardiac rhythm management devices market growth is driven by factors such as increasing focus on preventive healthcare and growing adoption of technologically advanced devices for treatment. However, risks associated with implantation of cardiac devices and pricing pressures can hamper the market growth.

Increasing incidence of cardiovascular diseases

Rising prevalence of cardiovascular diseases can drive the market growth. According to the World Health Organization, cardiovascular diseases currently account for over 17 million deaths annually, with low- and middle-income countries disproportionately impacted. Rising burden of cardiovascular diseases can be attributed to both genetic predisposing factors as well as lifestyle and environmental risk factors prevalent in modern societies. Changes in dietary patterns along with reduced physical activity contribute to increased incidence of obesity, diabetes and unhealthy cholesterol levels, all of which are known risk multipliers for developing cardiovascular conditions. Moreover, growing geriatric population can also drive the market growth as age is a significant risk factor of the disease due to deteriorating functionality of organs with time.